217 related articles for article (PubMed ID: 3485265)
1. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
2. Roxithromycin (RU 28965) in the treatment of respiratory tract infections.
Grassi C; Bertoletti R; De Rose V; Manara G; Mangiarotti P
Chemioterapia; 1987 Feb; 6(1):41-4. PubMed ID: 3103931
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of ceftriaxone.
File TM; Tan JS; Salstrom SJ
Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
[TBL] [Abstract][Full Text] [Related]
8. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
Paniara O; Platsouka E; Dimopoulou H; Constantoulaki S
J Chemother; 1994 Feb; 6(1):35-8. PubMed ID: 8071676
[TBL] [Abstract][Full Text] [Related]
10. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
[TBL] [Abstract][Full Text] [Related]
12. [Cefotaxime in bronchopulmonary infections (author's transl)].
Kermarec J; Sauvaget J
Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
[TBL] [Abstract][Full Text] [Related]
13. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
Zientara M; Rudy M; Nowakowska M; Martirosian G
Med Dosw Mikrobiol; 2006; 58(3):239-45. PubMed ID: 17340999
[TBL] [Abstract][Full Text] [Related]
14. [Bacterial infectious agents implicated in lower respiratory tract infections in general practice].
Vernejoux JM; Texier-Maugein J; Rio P; Guizard AV; Tunon de Lara JM; Taytard A
Rev Pneumol Clin; 1997; 53(3):138-43. PubMed ID: 9296114
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders.
Salari MH; Amine G; Shirazi MH; Hafezi R; Mohammadypour M
Clin Microbiol Infect; 2006 Feb; 12(2):194-6. PubMed ID: 16441463
[TBL] [Abstract][Full Text] [Related]
16. Respiratory infections: clinical evaluation.
Grassi C
Clin Ther; 1985; 7 Suppl A():45-54. PubMed ID: 3907845
[TBL] [Abstract][Full Text] [Related]
17. International experiences with ceftriaxone in the treatment of lower respiratory tract infections.
Grassi C; Mangiarotti P
Chemioterapia; 1987 Oct; 6(5):364-73. PubMed ID: 3322589
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of the in vitro and in vivo antibacterial activity of ceftriaxone and piperacillin: determination of the inhibitory quotient in bronchial secretions].
Fraschini F; Scaglione F; Ripamonti L; Cogo R; Casali W
Recenti Prog Med; 1988 May; 79(5):224-9. PubMed ID: 3051198
[No Abstract] [Full Text] [Related]
19. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
20. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
